BioWorld MedTech

Feb. 25, 2011

Deals roundup: Thermo Fisher in plan to sell diagnostic labs for $940M

Thermo Fisher Scientific (Waltham, Massachusetts) reported that it has signed definitive agreements to sell Athena Diagnostics (Worcester, Massachusetts) to Quest Diagnostics (Madison, New Jersey) for $740 million. (Medical Device Daily) Read More

Cook launches EchoTip ProCore, new histology needle for EUS

International report: Mazor's PIPE dreams up $6.3M in new capital funds for company

RFID Hospial Smart Room uses real-time patient data

Agreements/contracts: Masimo to license Pulse for Royal Fornia monitors

MDD's food for med-tech thought

New ventures: Biolase Technology forms new imaging business unit

Clarification

Product Briefs

HIT roundup: Lumedx launches Enabling EHR suite for meaningful use

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Aug. 19, 2025.

Handshake with dollar sign and checkmark

Skyhawk’s small-molecule RNA efforts draw Merck KGaA in $2B deal

BioWorld

Adding another name to an impressive roster of partners assembled over the past few years, Skyhawk Therapeutics Inc. inked a neurology-focused deal with Merck...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Aug. 19, 2025.

CSL to shave off 3,000 jobs, Seqirus vaccine unit

BioWorld

CSL Ltd.’s stock tumbled 16.88% on the news that it plans to cut 3,000 jobs and to hive off its Seqirus vaccine unit in a cost-cutting measure to save more than...

Woman measuring her body fat with caliper

GI blow: Viking soldiers on with midstage oral obesity bid

BioWorld

Rates of adverse events (AEs) gave pause to some on Wall Street, and shares of Viking Therapeutics Inc. (NASDAQ:VKTX) fell 42%, or $17.73, to close Aug. 19 at...